Speaker illustration

Professor Gunnar Hilmar Gislason

Copenhagen University Hospital Herlev and Gentofte, Copenhagen (Denmark)

Member of:

European Society of Cardiology

Gunnar Gislason is a professor of cardiology at the University of Copenhagen and the Chief Medical Science Officer of the Danish Heart Foundation. His main research focus is the epidemiology, prevention and treatment of cardiovascular disease based on large-scale registries and randomized clinical trials. There is focus on drug-safety and drug-drug interactions, compliance, cardiac arrest as well as cardiovascular complications related to diabetes and metabolic disease. Dr. Gislason heads two research groups at the Danish Heart Foundation and the Copenhagen University Hospital Herlev- Gentofte, respectively, comprising more than 50 active researchers and an annual funding exceeding €2.5 million. Dr. Gislason is the author of more than 800 peer-reviewed scientific papers and his research groups publishes more than 120 scientific papers annually. Dr. Gislason has a major role in structuring and developing nationwide cardiovascular registries in Denmark.

Coronary artery disease - Epidemiology, prognosis, outcome 1

Event: ESC Congress 2022

Topic: Epidemiology, Prognosis, Outcome

Session type: Moderated ePosters

Thumbnail

Adverse outcomes in atrial fibrillation: can they be prevented?

Event: ESC CONGRESS 2019

Topic: Epidemiology, Prognosis, Outcome

Session type: Advances in Science

Thumbnail

ESC 365 is supported by

logo Novo Nordisk